Real-World Experience With Oleogel-S10 for Wounds in Epidermolysis Bullosa大疱性表皮松解症伤口使用Oleogel-S10的临床实践经验JEADV CLINICAL PRACTICEIF02025-09-010OAAI
Safety and tolerability of losartan to treat recessive dystrophic epidermolysis bullosa in children (REFLECT): an open-label, single-arm, phase 1/2 trialECLINICALMEDICINEIF102024-11-010OAAI
Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosaJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFTIF3.82024-04-282OAAI
IL-6 levels dominate the serum cytokine signature of severe epidermolysis bullosa: A prospective cohort studyJOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGYIF82024-02-203OAAI
Predominance of Staphylococcus Correlates with Wound Burden and Disease Activity in Dystrophic Epidermolysis Bullosa: A Prospective Case-Control StudyJOURNAL OF INVESTIGATIVE DERMATOLOGYIF5.72022-08-0111OAAI
Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosaJCI INSIGHTIF6.12021-11-2232OAAI
A single preoperative FGF23 measurement is a strong predictor of outcome in patients undergoing elective cardiac surgery: a prospective observational studyCRITICAL CAREIF9.32015-12-0122OAAI